ALIGN TECHNOLOGY INC(ALGN)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

ALIGN TECHNOLOGY INC (ALGN) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores ALGN at 58.9/100 on a 32-signal composite quality model, placing it at rank #965 of 2,961 stocks — the top half of the AI-ranked universe. ALGN scores in the top quartile across earnings quality (81.1), institutional flow (77.5), balance sheet strength (75.6). Areas of concern include revenue growth (30.6), which score below median versus the broader universe. Shareholder dilution risk is elevated at 26.0/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), ALIGN TECHNOLOGY INC reports quarterly revenue of $1.1B, net income of $108.3M, an operating margin of 14.6%. Top institutional holders of ALGN by reported 13-F value include BlackRock, VANGUARD CAPITAL MANAGEMENT, FMR, based on the most recent SEC filings. ALGN trades on the Nasdaq exchange and files with the SEC under CIK 1097149. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ALGN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for ALIGN TECHNOLOGY INC directly from SEC EDGAR.